Association of pentraxin-3 with the severity of rheumatic mitral valve stenosis

Acta Cardiologica
|October 13, 2015
PubMed
Abstract

Insights

Elevated Pentraxin-3 (PTX3) levels are associated with rheumatic mitral valve stenosis (RMVS) severity. PTX3 may play a role in RMVS, offering a potential biomarker for this inflammatory heart condition.

Area of Science:

  • Cardiology
  • Inflammation Research
  • Biomarker Discovery

Background:

  • Inflammation is implicated in rheumatic mitral valve stenosis (RMVS) pathogenesis.
  • Pentraxin-3 (PTX3) is a marker of human inflammatory states.
  • Circulating PTX3 levels in RMVS patients are not well understood.

Purpose of the Study:

  • To investigate the association between PTX3 levels and RMVS severity.
  • To compare PTX3 levels in RMVS patients versus healthy controls.

Main Methods:

  • Included 41 RMVS patients and 31 healthy controls.
  • Measured circulating PTX3 and high-sensitivity C-reactive protein (hsCRP) levels.
  • Correlated PTX3 with clinical severity scores (Wilkins score) and echocardiographic parameters.

Main Results:

  • RMVS patients exhibited significantly higher PTX3 and hsCRP levels than controls.
  • PTX3 levels were more significantly elevated than hsCRP in RMVS patients.
  • PTX3 positively correlated with RMVS severity indicators like Wilkins score and left atrial diameter.

Conclusions:

  • Plasma PTX3 and hsCRP levels are increased in RMVS patients.
  • PTX3 shows a stronger association with RMVS severity compared to hsCRP.
  • PTX3 may be involved in the pathophysiology of RMVS, suggesting its potential as a biomarker.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
465
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.0K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
449
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
495
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
797